{"id":798060,"date":"2025-01-06T09:12:50","date_gmt":"2025-01-06T14:12:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\/"},"modified":"2025-01-06T09:12:50","modified_gmt":"2025-01-06T14:12:50","slug":"kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\/","title":{"rendered":"Kuehn Law Encourages MRNS, OMIC, LBRDA, and VCSA Investors to Contact Law Firm"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, Jan.  06, 2025  (GLOBE NEWSWIRE) &#8212; Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies.<\/p>\n<p>Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:12pt;margin-bottom:8pt\">\n          <strong><br \/>\n            <u>Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS)<\/u><br \/>\n          <\/strong><br \/>\n          <a href=\"https:\/\/www.kuehn.law\/join-an-action-sign\" rel=\"nofollow\" target=\"_blank\"><br \/>\n            <strong><br \/>\n              <u>Click to Take Action<\/u><br \/>\n            <\/strong><br \/>\n          <\/a><br \/>\n          <a href=\"https:\/\/www.kuehn.law\/join-an-action-sign\" rel=\"nofollow\" target=\"_blank\"><br \/>\n            <br \/>\n          <\/a>\n        <\/li>\n<\/ul>\n<p>Marinus Pharmaceuticals has entered into a definitive agreement with Immedica Pharma AB for $0.55 per share. The transaction is valued at approximately $151 million and is expected to close in the first quarter of 2025.<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">\n          <strong><br \/>\n            <u>Singular Genomics Systems, Inc. (NASDAQ: OMIC)<\/u><br \/>\n          <\/strong><br \/>\n          <a href=\"https:\/\/www.kuehn.law\/join-an-action-sign\" rel=\"nofollow\" target=\"_blank\"><br \/>\n            <strong><br \/>\n              <u>Click to Take Action<\/u><br \/>\n            <\/strong><br \/>\n          <\/a><br \/>\n          <a href=\"https:\/\/www.kuehn.law\/join-an-action-sign\" rel=\"nofollow\" target=\"_blank\"><br \/>\n            <br \/>\n          <\/a>\n        <\/li>\n<\/ul>\n<p>Singular Genomics Systems, Inc. has agreed to be acquired by an affiliate of Deerfield Management Company, L.P. in an all cash transaction for $20.00 per share. Upon completion of the transaction, Singular Genomics will become a private company.<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">\n          <strong><br \/>\n            <u>Liberty Broadband Corporation (NASDAQ: LBRDA)<\/u><br \/>\n          <\/strong><br \/>\n          <a href=\"https:\/\/www.kuehn.law\/join-an-action-sign\" rel=\"nofollow\" target=\"_blank\"><br \/>\n            <strong><br \/>\n              <u>Click to Take Action<\/u><br \/>\n            <\/strong><br \/>\n          <\/a><br \/>\n          <a href=\"https:\/\/www.kuehn.law\/join-an-action-sign\" rel=\"nofollow\" target=\"_blank\"><br \/>\n            <br \/>\n          <\/a>\n        <\/li>\n<\/ul>\n<p>Liberty Broadband Corporation has entered into a definitive agreement with Charter Communications. Under the terms of the agreement, Liberty Broadband shareholders will receive 0.236 Charter shares per share owned.<\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:12pt;margin-bottom:8pt\">\n          <strong><br \/>\n            <u>Vacasa, Inc. (NASDAQ: VCSA)<\/u><br \/>\n          <\/strong><br \/>\n          <a href=\"https:\/\/www.kuehn.law\/join-an-action-sign\" rel=\"nofollow\" target=\"_blank\"><br \/>\n            <strong><br \/>\n              <u>Click to Take Action<\/u><br \/>\n            <\/strong><br \/>\n          <\/a><br \/>\n          <a href=\"https:\/\/www.kuehn.law\/join-an-action-sign\" rel=\"nofollow\" target=\"_blank\"><br \/>\n            <br \/>\n          <\/a>\n        <\/li>\n<\/ul>\n<p>Vacasa, Inc. entered a merger agreement with Casago in a cash deal worth $110.56 million. As per the terms of the agreement, Casago will acquire all outstanding shares of Vacasa held by stockholders for $5.02 per share, representing a 31.76% premium from the stock\u2019s last close.<\/p>\n<p>\n        <strong>Why Your Participation Matters: <\/strong>\n      <\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OqilugtMdbkA9EJ0fu7wInNVtrm9_Qkl-ka2a9dKwwZFaX-2-iO9jEewYbmYYl8Iqen6Ck1UHt1zs8eNlcfKuXNxZASx3AGFzAuGZ4owLjL4yzcxonjKZIr1WQ3b2r3On4rXsKrSACutBL9hDA9G5w==\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong><br \/>\n            <u>SHAREHOLDER CASES: ADDRESSING THE INJUSTICE<\/u><br \/>\n          <\/strong><br \/>\n        <\/a>\n      <\/p>\n<p>As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. <em>Your investment. Your voice. Your future.<\/em>\u2122<\/p>\n<p>\n        <strong>How to Get Involved:<\/strong>\n      <\/p>\n<p>Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact the Firm at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sQ69Gkq4ibvQbaivJrDPiZqdxIJqtDtW40lZXBQHPfYSjPfQ7wjgCb40ArqN-9ROjbUQHqJz7DpuVT8-_sdwpQ==\" rel=\"nofollow\" target=\"_blank\"><u>moon@kuehn.law<\/u><\/a> or call (833) 672-0814. <strong>Kuehn Law covers all case costs and does not charge its investor clients. <\/strong><em>Shareholders are advised to act promptly, as legal rights may be time-sensitive. <\/em> For additional information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=G8E7geGI7LnLCJlffOeXe4WF4crABDOQYHJaiFJyChV1Df-yHqENmtw-YPHqS2nyHH_mOHtcsl8lTt0p3tCJAS-M3WkLBXBpVVZ_b3KCuoMehJAxScsTc4xq5jHV1gNLqfg8Ds0RMqkeoIYqUYkeJw==\" rel=\"nofollow\" target=\"_blank\"><u>Merger Litigation &#8211; Kuehn Law<\/u><\/a>.<\/p>\n<p>Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>Contacts:<\/p>\n<p>Moon K. Young<br \/>Chief of Operations<br \/>Kuehn Law, PLLC<br \/>53 Hill Street, Suite 605 <br \/>Southampton, NY 11968<br \/>moon@kuehn.law<br \/>(833) 672-0814<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzAxMCM2NjgwMDc1IzIyODUyNTU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YWY5MTAzY2UtYzhiZi00Njc2LTk5YTMtNmIzMTkzODNiM2UxLTEyOTY4MDU=\/tiny\/KUEHN-LAW-PLLC.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) &#8212; Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies. Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process: Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) Click to Take Action Marinus Pharmaceuticals has entered into a definitive agreement with Immedica Pharma AB for $0.55 per share. The transaction is valued at approximately $151 million and is expected to close in the first quarter of 2025. Singular Genomics Systems, Inc. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Kuehn Law Encourages MRNS, OMIC, LBRDA, and VCSA Investors to Contact Law Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-798060","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kuehn Law Encourages MRNS, OMIC, LBRDA, and VCSA Investors to Contact Law Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kuehn Law Encourages MRNS, OMIC, LBRDA, and VCSA Investors to Contact Law Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) &#8212; Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies. Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process: Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) Click to Take Action Marinus Pharmaceuticals has entered into a definitive agreement with Immedica Pharma AB for $0.55 per share. The transaction is valued at approximately $151 million and is expected to close in the first quarter of 2025. Singular Genomics Systems, Inc. &hellip; Continue reading &quot;Kuehn Law Encourages MRNS, OMIC, LBRDA, and VCSA Investors to Contact Law Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-06T14:12:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzAxMCM2NjgwMDc1IzIyODUyNTU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Kuehn Law Encourages MRNS, OMIC, LBRDA, and VCSA Investors to Contact Law Firm\",\"datePublished\":\"2025-01-06T14:12:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\\\/\"},\"wordCount\":382,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNzAxMCM2NjgwMDc1IzIyODUyNTU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\\\/\",\"name\":\"Kuehn Law Encourages MRNS, OMIC, LBRDA, and VCSA Investors to Contact Law Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNzAxMCM2NjgwMDc1IzIyODUyNTU=\",\"datePublished\":\"2025-01-06T14:12:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNzAxMCM2NjgwMDc1IzIyODUyNTU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNzAxMCM2NjgwMDc1IzIyODUyNTU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kuehn Law Encourages MRNS, OMIC, LBRDA, and VCSA Investors to Contact Law Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kuehn Law Encourages MRNS, OMIC, LBRDA, and VCSA Investors to Contact Law Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\/","og_locale":"en_US","og_type":"article","og_title":"Kuehn Law Encourages MRNS, OMIC, LBRDA, and VCSA Investors to Contact Law Firm - Market Newsdesk","og_description":"NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) &#8212; Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies. Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process: Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) Click to Take Action Marinus Pharmaceuticals has entered into a definitive agreement with Immedica Pharma AB for $0.55 per share. The transaction is valued at approximately $151 million and is expected to close in the first quarter of 2025. Singular Genomics Systems, Inc. &hellip; Continue reading \"Kuehn Law Encourages MRNS, OMIC, LBRDA, and VCSA Investors to Contact Law Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2025-01-06T14:12:50+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzAxMCM2NjgwMDc1IzIyODUyNTU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Kuehn Law Encourages MRNS, OMIC, LBRDA, and VCSA Investors to Contact Law Firm","datePublished":"2025-01-06T14:12:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\/"},"wordCount":382,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzAxMCM2NjgwMDc1IzIyODUyNTU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\/","name":"Kuehn Law Encourages MRNS, OMIC, LBRDA, and VCSA Investors to Contact Law Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzAxMCM2NjgwMDc1IzIyODUyNTU=","datePublished":"2025-01-06T14:12:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzAxMCM2NjgwMDc1IzIyODUyNTU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzAxMCM2NjgwMDc1IzIyODUyNTU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kuehn-law-encourages-mrns-omic-lbrda-and-vcsa-investors-to-contact-law-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Kuehn Law Encourages MRNS, OMIC, LBRDA, and VCSA Investors to Contact Law Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/798060","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=798060"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/798060\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=798060"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=798060"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=798060"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}